Severe Acute Hepatitis B in HBV-Vaccinated Partner of a Patient with Multiple Myeloma Treated with Cyclophosphamide, Bortezomib, and Dexamethasone and Autologous Stem Cell Transplant

Hepatitis B reactivation can occur with various forms of immunosuppression. Cyclophosphamide, Bortezomib, and Dexamethasone (CYBOR-D) chemotherapy is commonly used for the treatment of multiple myeloma and has not been noted in guidelines to be causative in HBV reactivation. Indeed, current guidelin...

Descripción completa

Detalles Bibliográficos
Autores principales: Almaghrabi, Majed M., Fortinsky, Kyle J., Wong, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5385905/
https://www.ncbi.nlm.nih.gov/pubmed/28428898
http://dx.doi.org/10.1155/2017/2463953

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5385905/
https://www.ncbi.nlm.nih.gov/pubmed/28428898
http://dx.doi.org/10.1155/2017/2463953

Ejemplares similares